TRZ-8DXd

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameTRZ-8DXd
Drug Alias NameTrastuzumab exatecan derivative conjugate therapeutic (CHO Pharma/TE-Meds)1TRZ is conjugated to 8 molecules of exatecan derivative, DXd (CHO Pharma/TE-Meds)TRZ-8DXd
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Camptothecin derivative payload > MAAA-1181a payload
Mechanisms of ActionDNA topoisomerase I inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsDNA topoisomerase IReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCho Pharma IncT-E Meds Inc
China Registration ClassN/A

Develop Information

Active CompaniesT-E Meds Inc
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A